Atrial Electrocardiac Parameters for Left Atrial Pressure Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current techniques for detecting left atrial pressure (LAP) in heart failure patients using implantable medical devices face challenges due to the difficulty of directly sensing blood pressure in the left atrium, with impedance-based methods susceptible to non-cardiogenic influences, necessitating the development of alternative parameter-based detection methods.
Innovation Solution
The use of atrial electrocardiac parameters such as intra-atrial conduction delay (IACD) and P-wave duration, along with impedance measurements, to detect and confirm changes in LAP, allowing for more accurate estimation and confirmation of fluid overloads associated with congestive heart failure and pulmonary edema.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If impedance-based methods are used to estimate LAP, then non-invasive measurement is achieved, but measurement precision deteriorates due to susceptibility to non-cardiogenic influences
Solution Approach 1:
The patent introduces atrial electrocardiac parameters (IACD, P-wave duration) as intermediary indicators that mediate between the non-invasive ECG measurement and the target LAP parameter. These ECG parameters serve as reliable proxies that reflect LAP changes without requiring direct pressure measurement, thus maintaining non-invasive operation while improving measurement precision by filtering out non-cardiogenic impedance variations.
Solution Approach 2:
The patent replaces the mechanical impedance-based pressure estimation with an electrical signal-based approach using atrial electrocardiac parameters. By substituting mechanical impedance measurements with electrical ECG parameter analysis (IACD, P-wave duration), the system eliminates the susceptibility to non-cardiogenic influences while maintaining non-invasive measurement capability.
2Measurement precision
If direct blood pressure sensing in the left atrium is performed, then measurement precision is improved, but device complexity and risk increase due to trans-septal implant procedure
Solution Approach 1:
The patent uses atrial electrocardiac parameters as intermediary markers that can be measured through standard ECG leads without requiring complex trans-septal implantation. These ECG-based intermediaries (IACD, P-wave duration) provide accurate LAP information while avoiding the need for direct intracardiac pressure sensors, thus reducing device complexity and implant procedure risk.
Solution Approach 2:
The patent creates an electrical signal copy (ECG) of the mechanical pressure information through atrial depolarization characteristics. By measuring the electrical equivalents (IACD, P-wave duration) rather than direct mechanical pressure, the system obtains accurate LAP data without requiring invasive pressure transducers in the left atrium.
3Ease of operation
If impedance measurements are used to detect LAP changes, then ease of measurement is improved, but reliability deteriorates due to false positives from non-cardiogenic factors
Solution Approach 1:
The patent introduces atrial electrocardiac parameters (IACD, P-wave duration) as specific intermediary indicators that are selectively sensitive to cardiogenic LAP changes while being insensitive to non-cardiogenic factors. These ECG parameters act as filtered intermediaries that maintain ease of non-invasive measurement while significantly improving reliability by eliminating false positives from pneumonia, obesity, and other non-cardiac conditions.
Solution Approach 2:
The patent focuses measurement on the specific local quality of atrial electrical conduction characteristics (IACD, P-wave duration) rather than general impedance. This localized focus on atrial depolarization properties provides specificity to cardiogenic LAP changes, distinguishing them from non-cardiogenic impedance variations and improving detection reliability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables reliable detection and confirmation of elevated LAP, reducing false positives from non-cardiogenic factors, thereby improving diagnostic accuracy and therapeutic interventions in heart failure management.
Implementation Method 1
Atrial parameters affected by LAP, such as an intra-atrial conduction delay (IACD) or an atrial depolarization event (i.e. P-wave) duration, are detected within the electrocardiac signals
Implementation Method 2
a number of techniques have been developed that use electrical impedance (Z) to estimate LAP. For example, intracardiac impedance can be sensed along a sensing vector passing through the left atrium
Data Source
AI summary
Techniques are provided for assessing left atrial pressure (LAP) based on atrial electrocardiac signal parameters, particularly intra-atrial conduction delay (IACD) and P-wave duration. In one example, a pacemaker or other implantable device senses an intracardiac electrogram (IEGM) or a subcutaneous electrocardiogram (ECG), from which IACD and P-wave duration are derived. The device tracks changes, if any, in the parameters. A significant increase in either IACD or P-wave duration is associated with an increase in LAP. In some examples, conversion factors are calibrated for use with a particular patient to relate IACD and/or P-wave duration values to LAP values to provide an estimate of actual LAP. The conversion factors are pre-calibrated using LAP measurements obtained using a wedge pressure sensor. In other examples, IACD and P-wave duration are instead used to confirm the detection of an elevation in LAP initially made using impedance signals. Other confirmation parameters are described as well.